Previous 10 | Next 10 |
MELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health, wellness and serious disease is pleased to report annual results for the...
MELBOURNE, Australia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG, “Company”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to provide an update on the company’s activities via the lates...
2023-08-09 00:11:04 ET Genetic Technologies Limited (GENE) Q4 2023 Earnings Conference Call August 08, 2023 07:15 PM ET Company Participants Adrian Mulcahy - Investor Relations Simon Morriss - Chief Executive Officer Tony Di Pietro - Chief Financial Officer C...
2023-08-08 13:40:23 ET Genetic Technologies press release ( NASDAQ: GENE ): Q4'23 receipts were A$2.1M. Receipts from customers was A$8.8M for the 12 months to 30 June, up 29% Y/Y. For further details see: Genetic Technologies reports Q4 results
2023-08-07 11:20:35 ET Major earnings expected before the bell on Tuesday include: Duke Energy ( DUK ) Barrick Gold ( GOLD ) Medical Properties Trust ( MPW ) Organon ( OGN ) United Parcel Service ( UPS ) For further details see: Notable ea...
2023-07-28 13:26:38 ET Genetic Technologies ( NASDAQ: GENE ) said Friday its June-quarter receipts were A$2.1 million. At the end of June 2023, the company had A$7.9 million in cash and cash equivalents. Cash receipts from customers for the financial ye...
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, is pleased to provide this Quarterly Business Upda...
2023-07-21 09:07:39 ET Genetic Technologies ( NASDAQ: GENE ) has received notification from Nasdaq as it is not in compliance with the minimum bid price requirement. The closing bid price for the company’s ADS was below US$1.00 for 34 consecutive trading days. ...
MELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness and serious disease, advises that it has received notification (the “Notification”) from The Nasda...
MELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce that the Company’s geneType Brea...
News, Short Squeeze, Breakout and More Instantly...
Genetic Technologies Ltd Company Name:
GENE Stock Symbol:
NASDAQ Market:
Genetic Technologies Ltd Website:
CHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the power of the geneType test in identifyin...
CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and ...
CHARLOTTE, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, today announces the start of testing operations in the United St...